Pre-Approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)
Latest Information Update: 21 Sep 2023
At a glance
- Drugs Abiraterone acetate/niraparib (Primary) ; Prednisolone; Prednisone
- Indications Prostate cancer
- Focus Expanded access; Therapeutic Use
- Sponsors Janssen Research & Development
- 13 Sep 2023 Status changed from recruiting to completed.
- 09 Jun 2022 New trial record